News summaryYahoo Finance / BenzingaNov 8, 2026, 03:13 AM
Viridian Therapeutics Inc (VRDN) (Q3 2026) Earnings Call Highlights: Lumvoa's Strong Debut With ... - Yahoo Finance
Viridian said Lumvoa generated $24.7 million in net product revenue in its first quarter of launch. [[fact-kf7i1s7r8]] More than 100 patients had completed at least one infusion as of September 30. [[fact-g9jzs3h5u]] Cash, cash equivalents and marketable securities were just over $955 million at quarter-end. [[fact-qe3d8xzx2]] CMS assigned Lumvoa a permanent J-code effective January 1, 2027. [[fact-2mx8mpbyf]] The company provided no specific guidance for fourth-quarter patient additions or revenue. [[fact-5m7jb0kmt]]